Compare HOLX & SSNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HOLX | SSNC |
|---|---|---|
| Founded | 1985 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Electronics | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.9B | 17.8B |
| IPO Year | 1995 | 2007 |
| Metric | HOLX | SSNC |
|---|---|---|
| Price | $76.02 | $69.46 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 13 | 8 |
| Target Price | $77.89 | ★ $96.13 |
| AVG Volume (30 Days) | ★ 25.5M | 2.4M |
| Earning Date | 04-30-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 1.56% |
| EPS Growth | N/A | ★ 5.00 |
| EPS | 0.79 | ★ 3.15 |
| Revenue | ★ $4,100,500,000.00 | $1,675,295,000.00 |
| Revenue This Year | $4.74 | $9.20 |
| Revenue Next Year | $5.03 | $4.69 |
| P/E Ratio | $96.23 | ★ $22.02 |
| Revenue Growth | 1.74 | ★ 13.09 |
| 52 Week Low | $51.90 | $65.05 |
| 52 Week High | $76.07 | $91.07 |
| Indicator | HOLX | SSNC |
|---|---|---|
| Relative Strength Index (RSI) | 69.09 | 47.85 |
| Support Level | $75.10 | $65.05 |
| Resistance Level | N/A | $72.89 |
| Average True Range (ATR) | 0.19 | 1.83 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 95.19 | 50.93 |
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
SS&C Technologies provides software products and software-enabled services to a variety of customers primarily in financial services but also healthcare firms. Acquisitions are a large part of SS&C's history. SS&C GlobeOp provides fund administration services to alternative and traditional asset managers. In addition, SS&C provides portfolio accounting, portfolio management, trading, banking/lending, and other software to asset managers, banks, and financial advisors. SS&C's purchase of Intralinks makes it a leading player in virtual deal room solutions. With its 2018 purchase of DST Systems, SS&C gained a foothold in the healthcare industry with pharmacy health management solutions and medical claim administration services. In 2022, SS&C completed the acquisition of Blue Prism.